In spite of the fact that the role of GSK-3β in cancer cells as a pro-oncogenic or suppressor protein is debatable, it has been agreed that GSK3-β is a pro-tumor protein and a good candidate for the targeted treatment of pancreatic cancers [66]. The gene discussed is GSK3B; the disease is pancreatic neoplasm.